Close Menu

For the past few years, FDA has attempted to re-approve all the old drugs that made it to market before the current regulatory framework was in place. In an effort to catch up, the Wall Street Journal says, the regulatory body has been offering three years of market exclusivity to any company willing to do the clinical work and affirm the older drugs' efficacy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.

Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.

Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.

In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.